Xuejun Jin
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents 3
-
- Morinda citrifolia extract uses 3
- Cancer Research top 10%
- NF-κB Signaling Pathways 14
- Cancer, Hypoxia, and Metabolism 3
- Pharmacology top 5%
- Biochemistry top 5%
-
- Natural product bioactivities and synthesis 10
- Ubiquitin and proteasome pathways 4
- Bioactive natural compounds 3
-
- Immune Response and Inflammation 3
- Partner nations
- ChinaSouth KoreaVietnam
In The Last Decade
Xuejun Jin
30 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 110
- Toxicology 58
- Complementary and alternative medicine 139
- Cancer Research 245
- Pharmacology 125
- Biochemistry 93
Countries citing papers authored by Xuejun Jin
This map shows the geographic impact of Xuejun Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejun Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejun Jin more than expected).
Fields of papers citing papers by Xuejun Jin
This network shows the impact of papers produced by Xuejun Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejun Jin. The network helps show where Xuejun Jin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuejun Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2018 | 22 | |
| 5 | 2017 | 50 | |
| 6 | 2017 | 42 | |
| 7 | 2017 | 9 | |
| 8 | 2016 | 47 | |
| 9 | 2016 | 43 | |
| 10 | 2016 | 22 | |
| 11 | 2015 | 38 | |
| 12 | 2015 | 13 | |
| 13 | 2014 | 23 | |
| 14 | 2014 | 27 | |
| 15 | 2014 | 47 | |
| 16 | 2013 | 38 | |
| 17 | 2011 | 18 | |
| 18 | 2011 | 27 | |
| 19 | 2010 | 78 | |
| 20 | 2005 | 108 |
About Xuejun Jin
Xuejun Jin is a scholar working on Cancer Research, Toxicology and Complementary and alternative medicine, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (14 papers), Natural product bioactivities and synthesis (10 papers), Ubiquitin and proteasome pathways (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Bioactive natural compounds (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Morinda citrifolia extract uses (3 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Toxicology (58 citations), Complementary and alternative medicine (139 citations) and Cancer Research (245 citations). Xuejun Jin has collaborated with scholars based in China, South Korea and Vietnam. Frequent co-authors include Jung Joon Lee, Juan Ma, Chunliu Mi, Ke Si Wang, Hong Jin, Lian Xun Piao, Guang Xu, Xuezheng Li, Donghao Li and Jeong‐Hyung Lee.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.